B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Bemcentinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bemcentinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

bms
11 shared targets
semaxanib
7 shared targets
maleimide
9 shared targets
ilorasertib
8 shared targets
merestinib
6 shared targets
hematoxylin
5 shared targets
cabozantinib
10 shared targets
barasertib
7 shared targets
enmd
9 shared targets
pexidartinib
5 shared targets
Loading evidence profile...

This evidence profile for Bemcentinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.